Cargando…

Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity

Ectopic protein overexpression in immortalised cell lines is a commonly used method to screen host factors for their antiviral activity against different viruses. However, the question remains as to what extent such artificial protein overexpression recapitulates endogenous protein function. Previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Meischel, Tina, Fritzlar, Svenja, Villalón-Letelier, Fernando, Smith, Jeffrey M., Brooks, Andrew G., Reading, Patrick C., Londrigan, Sarah L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145288/
https://www.ncbi.nlm.nih.gov/pubmed/37111405
http://dx.doi.org/10.3390/pathogens12040519
_version_ 1785034297513607168
author Meischel, Tina
Fritzlar, Svenja
Villalón-Letelier, Fernando
Smith, Jeffrey M.
Brooks, Andrew G.
Reading, Patrick C.
Londrigan, Sarah L.
author_facet Meischel, Tina
Fritzlar, Svenja
Villalón-Letelier, Fernando
Smith, Jeffrey M.
Brooks, Andrew G.
Reading, Patrick C.
Londrigan, Sarah L.
author_sort Meischel, Tina
collection PubMed
description Ectopic protein overexpression in immortalised cell lines is a commonly used method to screen host factors for their antiviral activity against different viruses. However, the question remains as to what extent such artificial protein overexpression recapitulates endogenous protein function. Previously, we used a doxycycline-inducible overexpression system, in conjunction with approaches to modulate the expression of endogenous protein, to demonstrate the antiviral activity of IFITM1, IFITM2, and IFITM3 against influenza A virus (IAV) but not parainfluenza virus-3 (PIV-3) in A549 cells. We now show that constitutive overexpression of the same IFITM constructs in A549 cells led to a significant restriction of PIV-3 infection by all three IFITM proteins. Variable IFITM mRNA and protein expression levels were detected in A549 cells with constitutive versus inducible overexpression of each IFITM. Our findings show that overexpression approaches can lead to levels of IFITM1, IFITM2, and IFITM3 that significantly exceed those achieved through interferon stimulation of endogenous protein. We propose that exceedingly high levels of overexpressed IFITMs may not accurately reflect the true function of endogenous protein, thus contributing to discrepancies when attributing the antiviral activity of individual IFITM proteins against different viruses. Our findings clearly highlight the caveats associated with overexpression approaches used to screen cellular host proteins for antiviral activity.
format Online
Article
Text
id pubmed-10145288
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101452882023-04-29 Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity Meischel, Tina Fritzlar, Svenja Villalón-Letelier, Fernando Smith, Jeffrey M. Brooks, Andrew G. Reading, Patrick C. Londrigan, Sarah L. Pathogens Article Ectopic protein overexpression in immortalised cell lines is a commonly used method to screen host factors for their antiviral activity against different viruses. However, the question remains as to what extent such artificial protein overexpression recapitulates endogenous protein function. Previously, we used a doxycycline-inducible overexpression system, in conjunction with approaches to modulate the expression of endogenous protein, to demonstrate the antiviral activity of IFITM1, IFITM2, and IFITM3 against influenza A virus (IAV) but not parainfluenza virus-3 (PIV-3) in A549 cells. We now show that constitutive overexpression of the same IFITM constructs in A549 cells led to a significant restriction of PIV-3 infection by all three IFITM proteins. Variable IFITM mRNA and protein expression levels were detected in A549 cells with constitutive versus inducible overexpression of each IFITM. Our findings show that overexpression approaches can lead to levels of IFITM1, IFITM2, and IFITM3 that significantly exceed those achieved through interferon stimulation of endogenous protein. We propose that exceedingly high levels of overexpressed IFITMs may not accurately reflect the true function of endogenous protein, thus contributing to discrepancies when attributing the antiviral activity of individual IFITM proteins against different viruses. Our findings clearly highlight the caveats associated with overexpression approaches used to screen cellular host proteins for antiviral activity. MDPI 2023-03-27 /pmc/articles/PMC10145288/ /pubmed/37111405 http://dx.doi.org/10.3390/pathogens12040519 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Meischel, Tina
Fritzlar, Svenja
Villalón-Letelier, Fernando
Smith, Jeffrey M.
Brooks, Andrew G.
Reading, Patrick C.
Londrigan, Sarah L.
Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity
title Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity
title_full Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity
title_fullStr Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity
title_full_unstemmed Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity
title_short Caveats of Using Overexpression Approaches to Screen Cellular Host IFITM Proteins for Antiviral Activity
title_sort caveats of using overexpression approaches to screen cellular host ifitm proteins for antiviral activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145288/
https://www.ncbi.nlm.nih.gov/pubmed/37111405
http://dx.doi.org/10.3390/pathogens12040519
work_keys_str_mv AT meischeltina caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity
AT fritzlarsvenja caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity
AT villalonletelierfernando caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity
AT smithjeffreym caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity
AT brooksandrewg caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity
AT readingpatrickc caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity
AT londrigansarahl caveatsofusingoverexpressionapproachestoscreencellularhostifitmproteinsforantiviralactivity